chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: UNK
Symptoms: Nausea, Skin warm
Clinical narrative: C/O headache, shoulder pain, nausea for 3 days. (L) arm red, bruised, lump measures 21 x 25, (L) arm warm to touch.
Sex: U
Vaccine: FLUX
Symptoms: Arthralgia
Clinical narrative: This case was reported by a physician, via a GSK sales representative, that described the occurrence of arthralgia in a subject of unspecified age and gender, who was vaccinated with influenza virus vaccine (manufacturer unspecified). On an unspecified date, the subject received unspecified dose of Flu vaccine (unknown). At an unspecified time after vaccination with Flu vaccine, the subject experienced severe arthralgia. A physician reported to a sales representative that the subject experienced severe arthralgia that required treatment with Prednisone after receiving a flu vaccine. The reporting representative had limited information and was not certain that the flu vaccine received was FLUARIX. At the time of reporting, the outcome of the event was unspecified.
Age: 8.0
Sex: M
Vaccine: FLU3
Symptoms: Allergy test negative, Eczema, Inappropriate schedule of drug administration, Skin lesion, Skin reaction
Clinical narrative: This Case was reported by the mother of a consumer and described the occurrence of skin reactions (dermatological reaction) in an 8-year-old male subject who was vaccinated with influenza virus vaccine (flu vaccine, Glaxosmithkline). A physician or other health care professional has not verified this report. Concurrent medications included multivitamins. On 30 October 2006, in the afternoon, the subject received unspecified dose of flu vaccine at .25ml in an unknown arm. Two to four weeks after vaccination with flu vaccine, the subject developed what the mother referred to as a Dermatological reaction (skin reactions). A systemic reaction. He developed lesions (described as a nummular) on his hand, wrist, arms and the back of the ankles. It had been called eczema as well as some other Unidentifiable term (spongia). The condition responds to steroids, but when they are stopped the symptoms return. The subject has also been treated with Mupirocin and this worsened the lesions. The child has reportedly seen several dermatologists as well as allergists. He was tested for everything and it all comes back negative. The first flu vaccine the subject ever received was by Aventis and he ended up with over 300 lesions. At the time of reporting the outcome of the events was was unspecified. This was also considered to be a medication error as Glaxosmithkline flu vaccine in not indicated for use in pediatric subjects. These events occurred again in this subject in 2007 following vaccination with a Glaxosmithkline flu vaccine. Refer to case number A0739862A for details surrounding the second report.
Age: 9.0
Sex: M
Vaccine: FLU3
Symptoms: Allergy test negative, Eczema, Inappropriate schedule of drug administration, Skin lesion, Skin reaction
Clinical narrative: Skin reaction, Medication error, Nonspecific reaction, Skin lesion. Eczema, Adverse event. This case was reported by the mother of a consumer and described the occurrence of skin reactions (dermatological reaction) in a 9 year old male subject who was vaccinated with influenza virus vaccine (flu vaccine, Glaxosmithkline) for prophylaxis. A physician or other health care professional has not verified this report. Concurrent medications included Multivitamins. On 22-October- 2007, in the afternoon, the subject received unspecified dose of Flu vaccine, the subject developed what the mother referred to as a dermatological reaction (skin reaction). A systemic reaction. He developed lesions (described as nummular) on his hands, wrists, arms and the back of the ankles. It had been called eczema as well as some other unidentifiable term (spngia). The condition has lasted for about 8 months as of the time of reporting and the mother did report that there was only one lesion left. The condition responds to steroids, but when they are stopped the symptoms return. The subject has also been treated with mupirocin (clay park labs) and this worsened the lesions. The child has reportedly seen several dermatologists as well as allergist. Hwas tested for everything and it all comes back negative. the first flu vaccine the subject ever recieved was by aventis and he ended up with over 300 lesions. at the time of reporting the outcome of the events were unspecified. This was also considered to be a medication error as Glaxosmithkline flu vaccine is not indicated for use in pediatric subjects. These events occurred in this subject in 2006 following vaccianition with a Glaxosmithkline flu vaccine. Refer to case number A0739B53A for details surrounding the first report.
Age: 0.2
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC, RV5, DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Hypotonic-hyporesponsive episode
Clinical narrative: Initial report was received 17 September 2008 from a health care professional. A nine-week-old male infant with a history of GERD (gastroesophageal reflux disease) and "dacrostenosis" had received a first dose right thigh injection of PENTACEL, lot number C3175AA (route not reported), and a second dose left thigh injection of Hepatitis B vaccine, lot number 1884U (manufacturer Merck, route not reported), and a first dose left thigh injection of PREVNAR, lot number D05881 (manufacturer Wyeth, route not reported), and a first oral dose of ROTATEQ, lot number 0897X (manufacturer Merck) on 11 September 2008 and beginning five minutes after vaccination, he experienced "hypotonic - hyporesponsive episodes x5 after immunizations". The patient was hospitalization for 24 hours and recovered from the event. Laboratory and diagnostic testing had not been performed. Concomitant medications included ZANTAC and TYLENOL (0.8mL). No further information was provided at the time of the report.
Age: 17.0
Sex: M
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Oedema peripheral, Skin warm
Clinical narrative: Pt rcvd pneumococcal vaccine in L deltoid and influenza vaccine in right deltoid.  12 hours later pt arrived in ER with large injection site reaction on left arm with redness and swelling that went down onto the chest.  Area warm to touch. Pt BP elevated.  Pt rcvd IV antibiotics and discharged with oral antibiotics.  Pt to increase current prednisone dose from 20mg to 40mg for 1 day, then 30mg x 1 then back to 20 mg maintanance dose.
Age: 17.0
Sex: M
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Blood pressure increased, Erythema, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Pt rcvd pneumococcal vaccine in L deltoid and influenza vaccine in right deltoid.  12 hours later pt arrived in ER with large injection site reaction on left arm with redness and swelling that went down onto the chest.  Area warm to touch. Pt BP elevated.  Pt rcvd IV antibiotics and discharged with oral antibiotics.  Pt to increase current prednisone dose from 20mg to 40mg for 1 day, then 30mg x 1 then back to 20 mg maintanance dose.
Age: 17.0
Sex: M
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Local swelling
Clinical narrative: Pt rcvd pneumococcal vaccine in L deltoid and influenza vaccine in right deltoid.  12 hours later pt arrived in ER with large injection site reaction on left arm with redness and swelling that went down onto the chest.  Area warm to touch. Pt BP elevated.  Pt rcvd IV antibiotics and discharged with oral antibiotics.  Pt to increase current prednisone dose from 20mg to 40mg for 1 day, then 30mg x 1 then back to 20 mg maintanance dose.
Age: 21.0
Sex: F
Vaccine: HPV4
Symptoms: Electroencephalogram, Epilepsy, Grand mal convulsion, Laboratory test, Nuclear magnetic resonance imaging
Clinical narrative: Two days after first vaccination, experienced first grand mal seizure.  Second HPV vaccine two months later, second grand mal seizure within 4 days after vacinnation.  Since the second vaccine and seizure, two more grand mal seizures and several partial seizures.  At least 4 ER visits via ambulance due to seizures.  Abnormal MRI.  Course of anti-seizure medication begun.  Currently being followed by neurologist. Diagnosis of epilepsy.  No prior history of epilepsy or seizures.  No family history of epilepsy.
Age: 21.0
Sex: F
Vaccine: HPV4
Symptoms: Partial seizures, Vaccine positive rechallenge
Clinical narrative: Two days after first vaccination, experienced first grand mal seizure.  Second HPV vaccine two months later, second grand mal seizure within 4 days after vacinnation.  Since the second vaccine and seizure, two more grand mal seizures and several partial seizures.  At least 4 ER visits via ambulance due to seizures.  Abnormal MRI.  Course of anti-seizure medication begun.  Currently being followed by neurologist. Diagnosis of epilepsy.  No prior history of epilepsy or seizures.  No family history of epilepsy.
Age: 1.0
Sex: M
Vaccine: HEPA, PNC
Symptoms: Pyrexia
Clinical narrative: Son has fever of 102.3 now. Was given tylenol 5 hours ago. Is sleeping now.
Age: 0.3
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Injection site vesicles
Clinical narrative: According to father, infant's mother noticed 2 blisters on infant's left thigh while changing infant's diaper.  Father reports blisters on left thigh 2-3" bilaterally from knee cap.  One blister 1/2" in length and the other recently popped.  Father denies any fever, redness or swelling to left thigh.  Reports infant "normal".  Advised father per FNP to keep track and go to primary MD if worse.  *Infant received immunization shots 09-24-08: HIB and Prevnar to left thigh, Pediarix to right thigh.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Impaired work ability, Post herpetic neuralgia, Trigeminal nerve disorder
Clinical narrative: Information has been received from a nurse practitioner concerning a female in her 70's, with a history of Guillain-Barre syndrome who in Spring, approximately in March 2008, was vaccinated with ZOSTAVAX. On 01-MAY-2008, the patient developed zoster and post herpetic neuralgia. The patient has continued to have recurrent trigeminal lesions and post Herpetic Neuralgia. It was reported that the patient could not work. The patient's herpes zoster and post herpetic neuralgia were considered to be disabling. The patient sought medical attention in the physician's office. Additional information has been requested.
Age: 32.0
Sex: F
Vaccine: FLUX, HEP, IPV, MMR, TD
Symptoms: Drug exposure during pregnancy, Foetal disorder, Tuberculin test
Clinical narrative: Information has been received from a registered nurse concerning a 32 year old female with a positive TB skin test, and no drug reactions or allergies, who on 29 OCT 2007 was vaccinated with a second dose of MMR II (Enders-Edmonston, Jeryl Lynn, Wistar RA 27/3) (Lot # 652320/0092F). The patient had received a first dose of MMR II (Enders-Edmonston, Jeryl Lynn, Wistar RA 27/3) on 07-AUG-2007, while out of the country. The patient's husband reported to the nurse that the patient is now pregnant. The patient's LMP was 10 OCT 2007. Other vaccine therapy on 29 OCT 2007 included poliovirus vaccine, hepatitis B virus vaccine rHBsAg (manufacturer unknown), and influenza virus vaccine (unspecified). Follow-up information has been received through the Merck pregnancy registry from a registered nurse concerning this 32 year old female with no known drug allergies and a positive tuberculosis skin test who on 29-OCT-2007 was vaccinated with a second dose of MMR II (Enders-Edmonston, Jeryl Lynn, Wistar RA 27/3) (Lot # 652320/0092F). The patient received the first dose of MMR II (Enders-Edmonston, Jeryl Lynn, Wistar RA 27/3) on 07-AUG-2007, while out of the country. Other concomitant vaccinations on the same day included hepatitis B virus vaccine rHBsAg (manufacturer unknown), poliovirus vaccine inactivated (unspecified) (manufacturer unknown), influenza virus vaccine (unspecified) (manufacturer unknown) and diphtheria toxoid/tetanus toxoid (manufacturer unknown). The patient also had a tuberculosis skin test performed. It was noted that the patient delivered a female child on 05-JUL-2008. At 3 weeks old (on approximately 26-JUL-2008) the baby was hospitalized with meningitis for 3 weeks. The baby survived. At the time of the report, the baby's status was unknown. The nurse reported that she does not have all the medical details at this time, the family was traveling out of the country. Upon internal review the baby's meningitis was considered an other important medical event. Additional information has been requested.
Age: 25.0
Sex: F
Vaccine: HPV4
Symptoms: Computerised tomogram, Multiple sclerosis, Nuclear magnetic resonance imaging
Clinical narrative: Information has been received from a 24 year old female pharmacy technician with no allergies who on 25-JAN-2008 was vaccinated with the first dose of GARDASIL 0.5 ml (lot no. not reported) and on 26-MAR-2008, with second dose of GARDASIL 0.5 ml, (lot no. not reported). Concomitant therapy included hydrochlorothiazide (manufacturer unknown). On an unspecified date, the patient was diagnosed with multiple sclerosis and was hospitalized from 01-AUG-2008 to 20-AUG-2008. A magnetic resonance imaging (MRI) and a computed axial tomography were performed (results not reported). Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Abortion spontaneous, Chlamydia serology, Drug exposure during pregnancy, Laboratory test, Smear cervix
Clinical narrative: Information has been received from a registered nurse concerning a 14 year old female with a history of excess sweating and no drug reactions/allergies who on 16-Nov-2007 was vaccinated with the first dose of GARDASIL (lot#657617/0384U). Concomitant therapy included a first dose of Tdap and RUBINUL (therapy unspecified). On 22-Feb-2008, the patient was vaccinated intramuscularly with 0.5ml of the second dose of GARDASIL (lot# 657617/0384U) and found out she is pregnant (LMP = 26-JAN-2008). On an unspecified date GC test (gonorrhea and chlamydia test) and PAP test were performed (results pending). Also, on an unspecified date the patient took urine pregnancy test. Unspecified medical attention was sought in the office. Follow-up information was received. On 09-APR-2008 an ultrasound was performed which indicated a 9 weeks 2 days pregnancy. On an unspecified date the female patient experienced spontaneous abortion. The outcome of the spontaneous abortion was unknown. Upon internal review the spontaneous abortion was considered to be an other important medical event. Additional information is not expected.
Age: 14.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Ultrasound scan, Urine human chorionic gonadotropin positive
Clinical narrative: Information has been received from a registered nurse concerning a 14 year old female with a history of excess sweating and no drug reactions/allergies who on 16-Nov-2007 was vaccinated with the first dose of GARDASIL (lot#657617/0384U). Concomitant therapy included a first dose of Tdap and RUBINUL (therapy unspecified). On 22-Feb-2008, the patient was vaccinated intramuscularly with 0.5ml of the second dose of GARDASIL (lot# 657617/0384U) and found out she is pregnant (LMP = 26-JAN-2008). On an unspecified date GC test (gonorrhea and chlamydia test) and PAP test were performed (results pending). Also, on an unspecified date the patient took urine pregnancy test. Unspecified medical attention was sought in the office. Follow-up information was received. On 09-APR-2008 an ultrasound was performed which indicated a 9 weeks 2 days pregnancy. On an unspecified date the female patient experienced spontaneous abortion. The outcome of the spontaneous abortion was unknown. Upon internal review the spontaneous abortion was considered to be an other important medical event. Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: HEPA, HIBV, PNC
Symptoms: Hypersensitivity, Pyrexia, Serum sickness, Urticaria
Clinical narrative: The following information was obtained from the above-referenced literature article received on 11 September 2008. The article included background information on vaccine hypersensitivity and a detailed algorithm that provided a rational and organized approach for the evaluation and treatment of patients with suspected hypersensitivity. Also included were cases of suspected allergic reactions to vaccines to demonstrate the practical application of the algorithm. Information in this case pertains to a patient who experienced an allergic reaction, described as follows: "A 1-year-old child received hepatitis A (dose 1), pneumococcal conjugate (dose 4), and HiB (dose 4) vaccines. The next day, she developed low-grade fever (38.2 degrees Celsius) and diffuse hives except on the palms and soles. She was taken to an urgent care clinic, where she was given acetaminophen and diphenhydramine. The fever resolved, but the hives persisted for 4-5 days. She did not have any other symptoms. She was previously healthy with no relevant medical history, allergies, or atopic disease. The impression was that this most likely represented a serum sickness-like reaction, although an IgE-mediated, immediate-type reaction could not be ruled out. Also, an intercurrent infection could have caused the symptoms, which persisted for 5 days, and the vaccine may have played no role in the pathogenesis." The article did not report vaccine trade names, manufacturers, lot numbers, route/site of administration and date of administration. Application of the algorithm to this case was then described: "We recommended checking hepatitis A titers and referral to an allergist for skin testing before her next hepatitis A dose, beginning with a prick test to the full-strength vaccine followed by intradermal tests at 1:100 and 1:10 dilutions. Skin testing could have been performed to the pneumococcal conjugate and Hib vaccines, but this was considered optional because no additional doses of those vaccines would be needed. Negative skin tests suggest that the patient is unlikely to have an immediate-type reaction with future doses; however, skin tests have not been shown to have predictive value for serum sickness-like of other types of non-IgE mediated hypersensitivity reactions. As per the algorithm, if the skin test is positive, if she had hepatitis A antibody concentrations that are presumed to be protective, then we would withhold subsequent doses. If skin testing is positive but antibody concentrations are low and there is a significant concern about the risk of hepatitis A exposure, then a graded rechallenge with hepatitis A vaccine in a controlled environment that has the personnel and equipment to manage appropriately anaphylaxis or another serious adverse reaction would be recommended. This case is reported in the same literature article as case 2008-02851.
Age: 1.5
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Condition aggravated, Drug hypersensitivity, Pyrexia
Clinical narrative: Initial report received on 11 July 2008 from a health care professional. An 18-month-old male patient, who had a concurrent temperature of 99.1 degrees Fahrenheit, had received, per the reporter, on 08 July 2008 a first, intramuscular left thigh injection of TRIHIBIT, package lot number U15655C (TRIHIBIT is given as ACT-HIB and TRIPEDIA; however the specific lot numbers for these vaccines were not provided). An unspecified amount of time later, on the same day, the patient experienced a fever of 102.5 to 104.4 degrees Fahrenheit that fluctuated over the next four days. He was subsequently evaluated by his physician (date not reported) and prescribed Tylenol and Motrin for the fever. No diagnostic tests or laboratory data were performed. The recovery status of the patient was not reported. Follow up information was received on 14 August 2008 from a health care professional. The patient received an injection of ACTHIB (Z1011-2) and TRIPEDIA (U2059BB). The patient subsequently recovered from the events. No further information was reported. Follow up information was received on 15 September 2008 from a health care professional which resulted in an upgrade of the case from non-serious to serious. The recovery date was 17 July 2008. The only treatment the patient received was Tylenol. The patient's final diagnosis was drug allergy and the etiology was reported as vaccination. No further information was reported.
Age: 9.0
Sex: M
Vaccine: FLU3
Symptoms: Activated partial thromboplastin time normal, Blood culture negative, Contusion, Granulocyte count decreased, Haemoglobin normal
Clinical narrative: FLUZONE given 9/9/08. Had lice 9/15/08. Treated with NIX and homeopathic oils. Developed rash seen 9/19 (+) petechiae, bruising, platelet ct = 12. Admit Monday to hospital. Given Win-Rho suspect ITP.  11/26/08 MR received for DOS 9/19-20/2008 with DX: ITP. Pt presented with 1 wk hx of bruising with more recent addition of petechiae and purpura.  Platelet count of 12K at PMD's office.  Admitted for WinRho tx of thrombocytopenia.  Platelet count up to 35K prior to d/c. Will f/u as outpt.
Age: 9.0
Sex: M
Vaccine: FLU3
Symptoms: Idiopathic thrombocytopenic purpura, Lice infestation, Lymphocyte percentage, Monocyte percentage, Petechiae
Clinical narrative: FLUZONE given 9/9/08. Had lice 9/15/08. Treated with NIX and homeopathic oils. Developed rash seen 9/19 (+) petechiae, bruising, platelet ct = 12. Admit Monday to hospital. Given Win-Rho suspect ITP.  11/26/08 MR received for DOS 9/19-20/2008 with DX: ITP. Pt presented with 1 wk hx of bruising with more recent addition of petechiae and purpura.  Platelet count of 12K at PMD's office.  Admitted for WinRho tx of thrombocytopenia.  Platelet count up to 35K prior to d/c. Will f/u as outpt.
Age: 9.0
Sex: M
Vaccine: FLU3
Symptoms: Platelet count decreased, Prothrombin time normal, Rash, White blood cell count normal
Clinical narrative: FLUZONE given 9/9/08. Had lice 9/15/08. Treated with NIX and homeopathic oils. Developed rash seen 9/19 (+) petechiae, bruising, platelet ct = 12. Admit Monday to hospital. Given Win-Rho suspect ITP.  11/26/08 MR received for DOS 9/19-20/2008 with DX: ITP. Pt presented with 1 wk hx of bruising with more recent addition of petechiae and purpura.  Platelet count of 12K at PMD's office.  Admitted for WinRho tx of thrombocytopenia.  Platelet count up to 35K prior to d/c. Will f/u as outpt.
Age: 0.2
Sex: F
Vaccine: DTAP, HEP, IPV, PNC, RV5
Symptoms: Expired drug administered
Clinical narrative: Hepatitis B that was given was expired. No side effects reported.
Age: 0.5
Sex: M
Vaccine: DTAPH, IPV, PNC, RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: DTaP-HIB combo given before 15 months of age. No side effects reported.
Age: 0.3
Sex: F
Vaccine: DTAPH, IPV, PNC, RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: DTaP-HIB combo given before age 15 months. No side effect reported.
Age: 15.0
Sex: M
Vaccine: HEP, HEPA, MNQ
Symptoms: Expired drug administered
Clinical narrative: Hepatitis B that was given was expired. No side effects reported.
Age: 0.4
Sex: F
Vaccine: DTAPH, IPV, PNC, RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: DTAP-HIB given before 15 months of age.  No side effects reported.
Age: 0.4
Sex: F
Vaccine: DTAPH, IPV, PNC, RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: DTaP-HIB given before 15 months of age. no side effects reported.
Age: 0.5
Sex: M
Vaccine: DTAPH, IPV, PNC, RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: DTaP-HIB given to a child too young to receive vaccine. no side effects reported.
Age: 30.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Slight swelling, redness, warmth at site of injection.
Age: 0.4
Sex: F
Vaccine: DTAPH, IPV, PNC, RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: DTaP-HIB combo given before 15 months of age. No side effects reported.
Sex: M
Vaccine: DTAPH, IPV, PNC
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: DTaP-HIB combo given before age 15 months. no side effect reported.
Age: 0.4
Sex: M
Vaccine: DTAPH, IPV, PNC
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: DTAP-HIB combo given before 15 months of age.  No side effects reported.
Age: 1.3
Sex: M
Vaccine: DTAPH, IPV, PNC
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: DTaP-HIB combo given before 15 months of age. No side effects reported.
Age: 1.5
Sex: F
Vaccine: DTAPH, PNC
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: DTaP-HIB combo given before 15 months of age. no side effects reported.
Age: 2.0
Sex: M
Vaccine: HEPA
Symptoms: Convulsion
Clinical narrative: Received a call at 7 am on 9/19/08 from father that child had seizure and they were on the way to ER. No fever per dad. Seen at medical center.
Age: 29.0
Sex: F
Vaccine: UNK
Symptoms: Herpes zoster, Secondary transmission
Clinical narrative: Mother of the patient called our office and stated that she contracted shingles after the child received vaccines.  Her OBGYN stated that this "could be dangerous".
Age: 1.1
Sex: F
Vaccine: DTAP, HEPA, MMR, PNC
Symptoms: Erythema, Irritability, Oedema peripheral, Pyrexia
Clinical narrative: Child developed redness & swelling right thigh.  Fever to 101 degrees at home, very fussy.  Has 5x3cm area of erythema - not indurated.  Afebrile in clinic 9/19/08.
Age: 6.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Ataxia, Eye movement disorder, Head titubation, Hypokinesia
Clinical narrative: 2 days after immunization of VARIVAX and MMR 8/30-9/2 or 9/3 rocking and bobbing of head back and forth. Eye deviation to (R) and (C), trouble conducting fine motor (i.e. fork to mouth), ataxia.
Age: 1.1
Sex: M
Vaccine: HEPA, PNC
Symptoms: Erythema, Joint swelling
Clinical narrative: (L) knee and thigh reddened and swollen.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling at an injection site.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Culture throat negative, Immunisation reaction, Induration, Pallor, Pyrexia
Clinical narrative: Seen in office 9/18 with 3 day hx of fever and rash. Fine blanching red macular rash on trunk and neck. Left thigh with red slightly indurated area about 1 cm. Provider felt it was MMR reaction. Called parent on 9/22; rash improved, afebrile.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Rash, Rash macular
Clinical narrative: Seen in office 9/18 with 3 day hx of fever and rash. Fine blanching red macular rash on trunk and neck. Left thigh with red slightly indurated area about 1 cm. Provider felt it was MMR reaction. Called parent on 9/22; rash improved, afebrile.
Sex: F
Vaccine: HPV4
Symptoms: Injection site irritation, Injection site pain
Clinical narrative: Information has been received from a registered nurse concerning female patients of various ages who were vaccinated with GARDASIL.  All her patients who received GARDASIL experienced injection site pain and burning immediately upon injection.  This has caused some of the patients to not return for their subsequent doses.  The patients recovered while they were in the office.  These symptoms occurred with any dose of the series.  The patients sought unspecified medical attention.  Follow up information was received from the nurse stating that, she was not aware of any specific patients but rather a general statement was made regarding patients experiencing injection site pain and burning.  With HIPAA, the nurse would not feel comfortable providing any patient information anyway.  As this was a general statement, there will be no patient information coming from this office.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Influenza like illness, Insomnia, Muscle spasms, Nausea, Pyrexia
Clinical narrative: Information has been received from a consumer concerning her daughter, a 15 year old female with a sulfa allergy and no pertinent medical history, who on 02-JUN-2008 was vaccinated with a dose of GARDASIL.  There was no concomitant therapy.  The patient developed fever, cramps, nausea and flu-like symptoms the day of vaccination or the day after.  She had difficulty sleeping that night.  The consumer called the physician.  No lab diagnostic studies were performed.  The patient took TYLENOL and ADVIL.  The symptoms resolved the next day.  Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: VARCEL
Symptoms: Pain in extremity
Clinical narrative: One day after receiving varicella vaccine, patient experienced pain in entire (L) arm.  No fever, no arm swelling.  Patient continues to have pain in entire (L) arm one week later.
Age: 1.25
Sex: F
Vaccine: VARCEL
Symptoms: Injection site induration, Pyrexia, Rash morbilliform
Clinical narrative: Knot at injection site, high fever for 4 days, measle like rash
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMR, VARZOS
Symptoms: Injection site erythema, Injection site inflammation, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Per Mother -  Right arm swelling from shoulder to elbow.  Red, inflamed, pain at injustion site.  Low grade fever.
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMR, VARZOS
Symptoms: Wrong drug administered
Clinical narrative: Per Mother -  Right arm swelling from shoulder to elbow.  Red, inflamed, pain at injustion site.  Low grade fever.
Age: 81.0
Sex: F
Vaccine: PPV
Symptoms: Injection site induration, Injection site pain, Injection site swelling, Injection site warmth, Pain
Clinical narrative: COMPLAINED OF INCREASED PAIN IN UPPER LEFT ARM, SITE OF PNEMONOCOCCAL VACCINE. SITE IS VERY SWOLLEN, WARM TO TOUCH AND HARD FROM THE SHOULDER TO APPROX 4 INCHES DOWN ARM. PAIN AND DECREASED RANGE OF MOTION DUE TO THE PAIN.  11/14/2008 MR received for DOS 9/23-/28/08. Pt admitted for CVA and received Pneumovax during hospital stay. No mention of any reaction in D/C summary. Case closed
Age: 5.0
Sex: M
Vaccine: DTAP, FLUN3, IPV, MMR, VARCEL, DTAP, FLUN3, IPV, MMR, VARCEL, DTAP, FLUN3, IPV, MMR, VARCEL
Symptoms: Depressed level of consciousness, Dysphagia, Eyelid oedema, Flushing, Lip swelling
Clinical narrative: 30 minutes after leaving our office after receiving immunizations at his well child check, patient returned with mother. At the time of return he was flushed with hives present; eyelids, tongue, and lips swollen; pt was having difficulty swallowing; decreased responsiveness (eyes open but not talking).  911 called. Tachycardic on exam by Dr.  Respiratory rate normal. Epi-pen Jr administered to left thigh. Oxygen saturation was 96-98%.  Paramedics arrived with in 5 minutes and patient was transported to hospital in stable condition for further evaluation and treatment.
Age: 5.0
Sex: M
Vaccine: DTAP, FLUN3, IPV, MMR, VARCEL, DTAP, FLUN3, IPV, MMR, VARCEL, DTAP, FLUN3, IPV, MMR, VARCEL
Symptoms: Oxygen saturation normal, Respiratory rate, Swollen tongue, Tachycardia, Urticaria
Clinical narrative: 30 minutes after leaving our office after receiving immunizations at his well child check, patient returned with mother. At the time of return he was flushed with hives present; eyelids, tongue, and lips swollen; pt was having difficulty swallowing; decreased responsiveness (eyes open but not talking).  911 called. Tachycardic on exam by Dr.  Respiratory rate normal. Epi-pen Jr administered to left thigh. Oxygen saturation was 96-98%.  Paramedics arrived with in 5 minutes and patient was transported to hospital in stable condition for further evaluation and treatment.
Age: 5.0
Sex: M
Vaccine: DTAP, FLUN3, IPV, MMR, VARCEL, DTAP, FLUN3, IPV, MMR, VARCEL, DTAP, FLUN3, IPV, MMR, VARCEL
Symptoms: Drug hypersensitivity, Dysphagia, Eyelid oedema, Flushing, Hypokinesia
Clinical narrative: 30 minutes after leaving our office after receiving immunizations at his well child check, patient returned with mother. At the time of return he was flushed with hives present; eyelids, tongue, and lips swollen; pt was having difficulty swallowing; decreased responsiveness (eyes open but not talking).  911 called. Tachycardic on exam by Dr.  Respiratory rate normal. Epi-pen Jr administered to left thigh. Oxygen saturation was 96-98%.  Paramedics arrived with in 5 minutes and patient was transported to hospital in stable condition for further evaluation and treatment.
Age: 5.0
Sex: M
Vaccine: DTAP, FLUN3, IPV, MMR, VARCEL, DTAP, FLUN3, IPV, MMR, VARCEL, DTAP, FLUN3, IPV, MMR, VARCEL
Symptoms: Lip swelling, Swollen tongue, Tachycardia, Urticaria
Clinical narrative: 30 minutes after leaving our office after receiving immunizations at his well child check, patient returned with mother. At the time of return he was flushed with hives present; eyelids, tongue, and lips swollen; pt was having difficulty swallowing; decreased responsiveness (eyes open but not talking).  911 called. Tachycardic on exam by Dr.  Respiratory rate normal. Epi-pen Jr administered to left thigh. Oxygen saturation was 96-98%.  Paramedics arrived with in 5 minutes and patient was transported to hospital in stable condition for further evaluation and treatment.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Feeling hot, Pruritus generalised, Urticaria
Clinical narrative: Approx one hour after receiving the flu vaccine, she noticed body itching, hot feeling. light headed.  After two hours, developed hives on left arm which was the arm of vaccination. Saw Dr. who recommended antihistamine. Pt took Benadryl. Felt better. Next day, still improving.
Age: 12.0
Sex: F
Vaccine: HEPA, MNQ
Symptoms: Dizziness, Eye disorder, Headache, Vision blurred
Clinical narrative: Within less than one minute of vaccination, client became dizzy and had blurry vision. Was laid down with cool packs and improved. Attempted a couple of times to have client sit up, but with any movement continued to get dizzy without change in vision, but eyes would appear glazed over. After approximately 20 minutes client complained of mild headache to right brow area of forehead. Symptoms continued for at least 45 minutes without full recovery and EMS was notified and transported client to Health Center ER.
Age: 1.25
Sex: M
Vaccine: HIBV, MMR, PNC, VARCEL
Symptoms: Rash
Clinical narrative: LIGHT COLORED RASH NOTED ON PATIENT'S TRUNK WHICH BEGAN ON 9/23/08. DOES NOT APPEAR TO ITCH. NO FEVER NOTED. NO TREATMENT NECESSARY AT THIS TIME.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Mother reports that child now has 2x2 inch red, swollen, warm area on arm where varicella vaccine was administered.
Age: 32.0
Sex: M
Vaccine: ANTH
Symptoms: Injection site induration
Clinical narrative: Large golfball-sized knot at the site of administration apporox. 8 days after recieving the vaccine. This was patient's 6th dose of the anthrax vaccine.
Age: 88.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Pt reported (3 months later) that she developed herpes zoster approximately 10 days after receiving Zostavax on 5/22/08.   Pt did not seek medical treatment. Pt was on 15mg prednisone at time of vaccination and had been on 20 mg prednisone for months prior to decreasing dose 5 weeks prior to vaccination.
Sex: F
Vaccine: FLUN3
Symptoms: Confusional state, Dizziness, Dyspnoea, Feeling hot
Clinical narrative: About two hours following vaccine administration feels hot, dizzy, faint, confuseddenies SOB
Age: 1.6
Sex: M
Vaccine: DTAP
Symptoms: Injection site cellulitis, Injection site rash, Injection site swelling, Injection site warmth, Rash erythematous
Clinical narrative: This previously healthy 1½-year-old male received a DTaP shot to his left thigh on 8/1 and, on 8/2, developed a rash on his left thigh. The rash worsened and he presented to the ED on 8/4 with an erythematous, somewhat blotchy macular rash encompassing approximately 70% of his thigh. The thigh was slightly swollen and warm to the touch. There was evidence of a puncture wound in the center of the rash that was consistent with a vaccination. The rash was consistent with cellulitis. He was started on clindamycin, admitted to the hospital, and discharged the same day.  10/6/08 Reviewed hospital medical records of 8/4/2008. FINAL DX: cellulitis left thigh/s/p vaccination; resolving acute left OM Records reveal patient experienced OM 8/1/08, tx w/oral antibiotics & given DTaP left thigh.  Developed macular blotchy rash left thigh next day.  Seen in outlying ER on 8/3, tx w/IM antibiotic, Rx for oral antibiotics & d/c to home.  Rash continued to worsen w/swelling & warmth of left thigh, fever 102.5 & admitted for IV antibiotics.  Improved & d/c home same day on continued oral antibiotics & PCP f/u.
Age: 1.6
Sex: M
Vaccine: DTAP
Symptoms: Rash macular, Wound
Clinical narrative: This previously healthy 1½-year-old male received a DTaP shot to his left thigh on 8/1 and, on 8/2, developed a rash on his left thigh. The rash worsened and he presented to the ED on 8/4 with an erythematous, somewhat blotchy macular rash encompassing approximately 70% of his thigh. The thigh was slightly swollen and warm to the touch. There was evidence of a puncture wound in the center of the rash that was consistent with a vaccination. The rash was consistent with cellulitis. He was started on clindamycin, admitted to the hospital, and discharged the same day.  10/6/08 Reviewed hospital medical records of 8/4/2008. FINAL DX: cellulitis left thigh/s/p vaccination; resolving acute left OM Records reveal patient experienced OM 8/1/08, tx w/oral antibiotics & given DTaP left thigh.  Developed macular blotchy rash left thigh next day.  Seen in outlying ER on 8/3, tx w/IM antibiotic, Rx for oral antibiotics & d/c to home.  Rash continued to worsen w/swelling & warmth of left thigh, fever 102.5 & admitted for IV antibiotics.  Improved & d/c home same day on continued oral antibiotics & PCP f/u.
Age: 5.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: Previously healthy child started with nausea/vomiting at 3:30am on 9/24 with subsequent fever between 38.3 C and 38.6 C developing on 9/24 at 12 noon. No fever as of 9/25. Only that single episode of vomiting.
Age: 28.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site rash, Rash
Clinical narrative: Pt returned to the office 1 hour after the injection with a rash at the site of injection. Rash extended from wrist to shoulder on the left arm.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Auricular swelling, Erythema, Lethargy, Lymphadenopathy, Ocular hyperaemia
Clinical narrative: Small macular-papular rash on chest, legs, abdomen, arms, face, neck, and behind both ears.  Bilateral pinna of both ears swollen and red.  Post cervical lynphadenopathy present.  Buccal mucosa-small half centimeter white bumps.  Bloodshot eyes.  Lethargy.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Oral mucosal discolouration, Rash maculo-papular
Clinical narrative: Small macular-papular rash on chest, legs, abdomen, arms, face, neck, and behind both ears.  Bilateral pinna of both ears swollen and red.  Post cervical lynphadenopathy present.  Buccal mucosa-small half centimeter white bumps.  Bloodshot eyes.  Lethargy.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Agitation, Crying, Eye swelling, Increased upper airway secretion, Pharyngolaryngeal pain
Clinical narrative: The patient came in for routine physical and his second varicella vaccine. He received the physical and vaccine and left the office. He returned to the office approximately 10-15 minutes after leaving with initial complaints of sore throat and his stomach "feeling bad". Per mom, he was vomiting but what was actually witnessed in the office was more like spitting up of phlegm and looking as though he wanted to vomit. He was crying and very agitated. Aprroximately 10 minutes later he developed swelling of his right eye (hives).  he was then sent to the ER where he was given oral and IV steroids and observed for 4-5 hours.  His symptoms subsided completely and he was sent home on a few days of oral steroids.  He has been fine since.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Stomach discomfort, Urticaria, Vomiting
Clinical narrative: The patient came in for routine physical and his second varicella vaccine. He received the physical and vaccine and left the office. He returned to the office approximately 10-15 minutes after leaving with initial complaints of sore throat and his stomach "feeling bad". Per mom, he was vomiting but what was actually witnessed in the office was more like spitting up of phlegm and looking as though he wanted to vomit. He was crying and very agitated. Aprroximately 10 minutes later he developed swelling of his right eye (hives).  he was then sent to the ER where he was given oral and IV steroids and observed for 4-5 hours.  His symptoms subsided completely and he was sent home on a few days of oral steroids.  He has been fine since.
Age: 14.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster, Pain, Rash
Clinical narrative: RASH ON SIDE OF FACE, NECK AND DOWN CHEST.  C/O PAIN.  DX WITH SHINGLE ON 9/25/08
Age: 4.0
Sex: F
Vaccine: DTAP
Symptoms: Erythema, Local swelling, Skin warm
Clinical narrative: After DTaP & IPV in Left shoulder, developed redness/warmth/swelling over 4x4cm area
Age: 12.0
Sex: F
Vaccine: HPV4, MEN
Symptoms: Dizziness, Dyspnoea, Dysstasia, Eyelid oedema, Pyrexia
Clinical narrative: Fever of 105, extreme dizziness to the point of being unable to stand on own, swelling in eyelids and face, and difficulty breathing. Called family doctor to confirm if this was a reaction to the HPV and they said to go to the ER, which we did. Today is one week after injection, and dizziness still occurs. The other symptoms are no longer visible.
Age: 12.0
Sex: F
Vaccine: HPV4, MEN
Symptoms: Swelling face
Clinical narrative: Fever of 105, extreme dizziness to the point of being unable to stand on own, swelling in eyelids and face, and difficulty breathing. Called family doctor to confirm if this was a reaction to the HPV and they said to go to the ER, which we did. Today is one week after injection, and dizziness still occurs. The other symptoms are no longer visible.
Age: 26.0
Sex: F
Vaccine: FLUN3
Symptoms: Nausea, Pregnancy test negative, Vomiting
Clinical narrative: 30 min after receiving vaccine, pt stated she had nausea and vomiting.  pt was given medication to help with nausea.
Age: 0.6
Sex: M
Vaccine: DTAPHEPBIP, PNC, RV5
Symptoms: Pyrexia
Clinical narrative: Vaccines given 9/23/08 at approximately 3:30 p.m.  On 9/24/08 client reports patient had a fever 105 degrees at 6:30 a.m. and taken to Hospital. Was discharged from hospital same day when fever was reduced with Tylenol and Motrin.  Client states patient will follow up with Dr today and is still having a fever of 103 degrees.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Condition aggravated, Head injury, Skin laceration, Swelling, Syncope
Clinical narrative: PT ADMIN. HPV VACCINE 15 MIN. AFTER ADMIN. PT FAINTED WHILE STANDING IN CHECK OUT LINE WITH FATHER AND HIT HER HEAD.V/S TAKEN BY NURSING STAFF AND PT WAS ASSESSED BY PHYSICAN LACERATION FOUND ABOVE LEFT BROW.AREA CLEANED AND ICE PACK APPLIED FOR SWELLING.PT D/C @11:35 AM. FATHER ADVISRD IF EPISODE HAPPENS AGAIN TO TAKE PT TO E.R.
Age: 0.2
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Blood culture negative, Cardio-respiratory arrest, Computerised tomogram abnormal, Culture urine negative, Lumbar puncture
Clinical narrative: Infant presented to emergency room with fever approximately 12 hours after vaccinations.  Admitted and started on empiric antibiotics.  Two days later, lumber puncture attempted with subsequent cardio-respiratory arrests.  4/7/09 Autopsy report states COD as complications of multiple congenital abnormalities & manner of death as natural.  Report also states multiple congenital abnormalities of: normal pressure hydrocephalus; patent foramen ovale; VSD; mildly atretic right dominant coronary artery system.  Also had UTI w/enterococcus faecalis, sepsis & lobar pneumonia.  Tox screen neg.
Age: 0.2
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Pyrexia
Clinical narrative: Infant presented to emergency room with fever approximately 12 hours after vaccinations.  Admitted and started on empiric antibiotics.  Two days later, lumber puncture attempted with subsequent cardio-respiratory arrests.  4/7/09 Autopsy report states COD as complications of multiple congenital abnormalities & manner of death as natural.  Report also states multiple congenital abnormalities of: normal pressure hydrocephalus; patent foramen ovale; VSD; mildly atretic right dominant coronary artery system.  Also had UTI w/enterococcus faecalis, sepsis & lobar pneumonia.  Tox screen neg.
Age: 0.1
Sex: M
Vaccine: DTP
Symptoms: Grand mal convulsion, Pyrexia
Clinical narrative: Patient received DPT shot and had high fever following administration. Approx 1 hour after administration pt suffered grand mal seizure. Taken to hospital.  11/25/08 Reviewed hospital medical records from 10/1995-12/1996. FINAL DX: recurrent respiratory tract infections; reactive airways disese; failure to thrive; hx of pertussis; RML pneumonia Records reveal patient initial hosp admit 11/20-11/25/1995 w/congestion, fever, reduced oral intake.  RSV (+) bronchiolitis.  Had bilateral inguinal hernia & left hydrocele repair 12/21/95.  Admitted 12/30-1/2/96 for viral gastroenteritis.  ENT clinic notes reveal prolonged OM despite antibiotic coverage.  Recurred OM 7/96. Had PE tube placement  & found left TM severely retracted.  Seen in ER multiple times for URI.  Admitted 11/26-11/28/1996 for status asthmaticus, presumptive pneumonia.  Admitted 12/4-12/11/1996 w/pertussis, posttussive vomiting & dehydration.  Pulmonary consult done & suggested immune w/u.  No further records available.  10/7/08 Reviewed PCP medical records. FINAL DX: migraine HAs; major depression; oppositional defiant disorder. Records reveal patient experienced hospitalization 10/20-10/30/1995 but no birth records attached (other records state hx of RDS).  8/21/06 neuro eval for migraine w/auras being tx w/depakote.  Hospitalized 9/20-9/29/2006 w/intermittent explosive disorder; major depression w/homicidal & suicidal features.  Seen in neuro clinic 11/23/2006 w/weight gain on current meds.  Most recent psych dx 2/2007 of oppositional defiant disorder.
Age: 47.0
Sex: M
Vaccine: FLUX
Symptoms: Chills, Influenza like illness, Pain, Pyrexia
Clinical narrative: Severe flu-like symptoms starting at 12M including high fever (103), chills, severe aching; Fever down to 101 at 5AM; took aspirin after calling emergency room; fever down to 100 at 6AM; fever and flu like symptoms thru 9/25/08 evening.